CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
Open Access
- 1 June 1993
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 177 (6), 1791-1796
- https://doi.org/10.1084/jem.177.6.1791
Abstract
The activation requirements for the generation of CD8+ cytotoxic T cells (CTL) are poorly understood. Here we demonstrate that in the absence of exogenous help, a CD28-B7 interaction is necessary and sufficient for generation of class I major histocompatibility complex-specific CTL. Costimulation is required only during the inductive phase of the response, and not during the effector phase. Transfection of the CD28 counter receptor, B7, into nonstimulatory P815 cells confers the ability to elicit P815-specific CTL, and this response can be inhibited by anti-CD28 Fab or by the chimeric B7-binding protein CTLA4Ig. Anti-CD28 monoclonal antibody (mAb) can provide a costimulatory signal to CD8+ T cells when the costimulatory capacity of splenic stimulators is destroyed by chemical fixation. CD28-mediated signaling provokes the release of interleukin 2 (IL-2) from the CD8+ CTL precursors, as anti-CD28 mAb could be substituted for by the addition of IL-2, and an anti-IL-2 mAb can block the generation of anti-CD28-induced CTL. CD4+ cells are not involved in the costimulatory response in the systems examined. We conclude that CD8+ T cell activation requires two signals: an antigen-specific signal mediated by the T cell receptor, and an additional antigen nonspecific signal provided via a CD28-B7 interaction.Keywords
This publication has 29 references indexed in Scilit:
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.Proceedings of the National Academy of Sciences, 1989
- LIMITING-DILUTION ANALYSIS OF HUMAN CTL DIFFERENTIATION - REQUIREMENT FOR A LYMPHOKINE-MEDIATED DIFFERENTIATION SIGNAL1988
- Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells.The Journal of Immunology, 1988
- Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells.The Journal of Experimental Medicine, 1987
- Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo.The Journal of Experimental Medicine, 1987
- Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.The Journal of Experimental Medicine, 1986
- Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens.The Journal of Experimental Medicine, 1985
- Helper activity is required for the in vivo generation of cytotoxic T lymphocytesThe Journal of Experimental Medicine, 1982
- Distinct Ir genes for helper and killer cells in the cytotoxic response to H-Y antigen.The Journal of Experimental Medicine, 1979